RALINEPAG REDUCES PULMONARY VASCULAR RESISTANCE (PVR) IN A PHASE 2 STUDY CONFIRMING PRECLINICAL FINDINGS ON PROSTACYCLIN (IP) RECEPTORS IN HUMAN TISSUES

Ioana R. Preston, Lucie H. Clapp, Namita Sood et al.|CHEST Journal|2018

Cited by 1